Roche, the Swiss pharmaceuticals giant, is caught in a race against time. After making a big bet on breakthrough drugs and personalized medicine, the company has spent much of the last 18 months thinking ahead to the challenges that machine learning and artificial intelligence pose to a traditional, integrated pharmaceutical business model.
Flatiron Health
The Power of Patient Data: How Flatiron Is Combining Big Data and Machine Learning to Revolutionize Cancer Care
With their machine learning-enabled OncoEMR platform, Flatiron is giving oncologists the power of big data at the point of patient care.